Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

Share Price is delayed by 15 minutes
Get Live Data
33.40    1.20 (3.73%)
Bid:
31.60
Ask:
32.80
Spread: 1.20 (3.797%)
Market Cap: £91.40m
GMR Live PriceLast checked at - London Stock Exchange

Intraday Gaming Realms Share Chart

Proctor & Gamble Update

21 May 2012 07:00

RNS Number : 7122D
Pursuit Dynamics PLC
21 May 2012
 



Pursuit Dynamics plc

("PDX" or the "Company")

Procter & Gamble Update

 

PDX (AIM:PDX), the developer of the PDX Atomiser and PDX Reactor products and technology, announces that the Company has been informed by Procter & Gamble ("P&G") that, following completion of their evaluation trials on 18 May, P&G does not intend to pursue further evaluation or development at this stage or enter into exclusive licensing discussions with PDX as the Company had envisaged under the Joint Development Agreement between PDX and P&G.

 

As a result of this, the Company's revenues for the year ending 30 September 2012 will be materially below the Company's earlier expectations. The Company has been undertaking a strategic review of the business and in light of the P&G decision the review will be accelerated to allow an update to be provided by the end of June 2012.

 

Interim CEO, Jeremy Pelczer, said: "We are obviously extremely disappointed with the decision by P&G. Although the resulting revenue shortfall will constrain growth we will continue to pursue a range of commercialisation opportunities while we conduct the strategic review."

 

Analyst and Investor Conference Call

There will be a conference call for analysts and investors at 9.00 a.m. on Thursday 24 May 2012, following the announcement of the interim results for the six months ended 31 March 2012.

 

Analysts and investors will be able to dial in using the following details:

Telephone Numbers: +44(0)20 3450 9987

Confirmation Code: 2499280

 

The conference call materials will be available via the company's website: www.pdx.biz

 

For further information please contact M:Communications

- ENDS -

 

Pursuit Dynamics

+44 (0)1480 422 050

Jeremy Pelczer, Interim CEO

Richard Webster, CFO

M:Communications

+44 (0) 20 7920 2330

Nick Miles

Matthew Neal

Cenkos Securities plc

+44 (0)20 7397 8924

Ian Soanes

Max Hartley

Mirabaud Securities

+44 (0)20 7878 3360

Rory Scott

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEAEFSFESELI
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20263:38 pmRNSTotal Voting Rights and Share Capital
2nd Jun 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares & Treasury Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20262:42 pmRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNS-RInvestor Presentation
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAnnual Results 2025
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.